Ying Feng

A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia

Heng Mei, Xiaofan Liu, Yan Li et al. · Journal of Hematology & Oncology · 2021 · 72 citations · Full text

Medicine, Hematology, Pharmacology +12

High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial

Yafei Yu, Miaomiao Wang, Yu Hou et al. · American Journal of Hematology · 2020 · 61 citations · Full text

Medicine, Hematology, Pharmacology +8

1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China

Xiaozhe Li, Wen-Ming Chen, Yin Wu et al. · The Oncologist · 2019 · 31 citations · Full text

Life Sciences, Genetics, Oncology +13

A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation

Lili Luo, Yingying Wu, Ting Niu et al. · Thrombosis Research · 2018 · 30 citations

Medicine, Hematology, Internal Medicine +14

Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients: A multicenter prospective study

Yingying Wu, Lili Luo, Ting Niu et al. · Scientific Reports · 2017 · 22 citations · Full text

Medicine, Hematology, Internal Medicine +14